, /PRNewswire/ -- Berger Montague，一家全國性的證券訴訟律師事務所，向 Hims &amp; Hers Health Inc.（&#34;Hims &amp; Hers&#34;或&#34;公司&#34;）（NYSE: HIMS）的股東通報，關於對 Hims &amp; Hers 董事會的調查，涉及其在與 Novo Nordisk A/S 終止合作關係時可能違反對公司及其股東的信託責任。
HIMS &amp; HERS 的股東可以通過聯繫 Berger Montague 瞭解更多關於此調查的信息：Radha Raghavan，電子郵件 [email protected] 或電話 (332) 271-8908，或 Andrew Abramowitz，電子郵件 [email protected] 或電話 (215) 875-3015，或通過點擊此處 .
Berger Montague 的調查重點是 Hims &amp; Hers 董事會在監督公司與 Novo Nordisk 的合作關係時是否違反了其信託責任，包括與 Novo Nordisk 在 2025 年 6 月宣佈終止與 Hims &amp; Hers 的合作關係有關，理由是公司在未獲批准的複合版本 semaglutide 的營銷中存在欺騙性行為。
Berger Montague 自 1970 年成立以來，一直是證券集體訴訟的先驅，擁有位於費城、明尼阿波利斯、特拉華州、華盛頓特區、聖地亞哥、舊金山、芝加哥、馬爾文（賓夕法尼亞州）和多倫多的辦事處。Berger Montague 在過去五十多年中代表個人和機構投資者，並在美國各地的法院擔任首席律師。
聯繫方式：
Radha Raghavan，助理
Berger Montague
(332) 271-8908
[email protected]
Andrew Abramowitz，高級顧問
Berger Montague
(215) 875-3015
[email protected]
來源：Berger Montague
<img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMDAzJk5ld3NJdGVtSWQ9REM5MDAzMiZUcmFuc21pc3Npb25fSWQ9MjAyNTEwMDMxMTM3UFJfTkVXU19VU1BSX19fX19EQzkwMDMy?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMDAzJk5ld3NJdGVtSWQ9REM5MDAzMiZUcmFuc21pc3Npb25fSWQ9MjAyNTEwMDMxMTM3UFJfTkVXU19VU1BSX19fX19EQzkwMDMy"/>

HIMS

Berger Montague 正在調查 Hims & Hers Health Inc.（紐約證券交易所代碼：HIMS）董事會可能存在的信託責任違規行為。這項調查是在諾和諾德（Novo Nordisk A/S）終止與 Hims & Hers 的合作關係後進行的，原因是其涉及與未經批准的複合版本 semaglutide 相關的欺騙性營銷行為。股東可以聯繫 Berger Montague 以獲取有關調查的更多信息

, /PRNewswire/ -- Berger Montague, a national securities litigation law firm, advises shareholders of Hims &amp; Hers Health Inc. (&#34;Hims &amp; Hers&#34; or the &#34;Company&#34;) ( NYSE: HIMS) about an investigation into Hims &amp; Hers' Board of Directors for potential breaches of fiduciary duties to the Company and its shareholders in connection with Novo Nordisk A/S's termination of its partnership with Hims &amp; Hers.
<div class="lb-trans">, /PRNewswire/ -- Berger Montague，一家全國性的證券訴訟律師事務所，向 Hims &amp; Hers Health Inc.（&#34;Hims &amp; Hers&#34;或&#34;公司&#34;）（NYSE: HIMS）的股東通報，關於對 Hims &amp; Hers 董事會的調查，涉及其在與 Novo Nordisk A/S 終止合作關係時可能違反對公司及其股東的信託責任。
</div>Shareholders of HIMS &amp; HERS may learn more about this investigation by contacting Berger Montague: Radha Raghavan at [email protected] or (332) 271-8908, or Andrew Abramowitz at [email protected] or (215) 875-3015 or by CLICKING HERE .
<div class="lb-trans">HIMS &amp; HERS 的股東可以通過聯繫 Berger Montague 瞭解更多關於此調查的信息：Radha Raghavan，電子郵件 [email protected] 或電話 (332) 271-8908，或 Andrew Abramowitz，電子郵件 [email protected] 或電話 (215) 875-3015，或通過點擊此處 .
</div>Berger Montague's investigation is focused on whether Hims &amp; Hers' Board of Directors breached its fiduciary duties in the manner in which it oversaw the Company's partnership with Novo Nordisk, including in connection with Novo Nordisk's announcement in June 2025 that it was terminating its partnership with Hims &amp; Hers on the basis that the Company had engaged in deceptive marketing practices with respect to unapproved compounded versions of semaglutide.
<div class="lb-trans">Berger Montague 的調查重點是 Hims &amp; Hers 董事會在監督公司與 Novo Nordisk 的合作關係時是否違反了其信託責任，包括與 Novo Nordisk 在 2025 年 6 月宣佈終止與 Hims &amp; Hers 的合作關係有關，理由是公司在未獲批准的複合版本 semaglutide 的營銷中存在欺騙性行為。
</div>Berger Montague, with offices in Philadelphia, Minneapolis, Delaware, Washington, D.C., San Diego, San Francisco, Chicago, Malvern, PA, and Toronto has been a pioneer in securities class action litigation since its founding in 1970. Berger Montague has represented individual and institutional investors for over five decades and serves as lead counsel in courts throughout the United States.
<div class="lb-trans">Berger Montague 自 1970 年成立以來，一直是證券集體訴訟的先驅，擁有位於費城、明尼阿波利斯、特拉華州、華盛頓特區、聖地亞哥、舊金山、芝加哥、馬爾文（賓夕法尼亞州）和多倫多的辦事處。Berger Montague 在過去五十多年中代表個人和機構投資者，並在美國各地的法院擔任首席律師。
</div>Contacts:
<div class="lb-trans">聯繫方式：
</div>Radha Raghavan, Associate
<div class="lb-trans">Radha Raghavan，助理
</div>Berger Montague
<div class="lb-trans">Berger Montague
</div>(332) 271-8908
<div class="lb-trans">(332) 271-8908
</div>[email protected]
<div class="lb-trans">[email protected]
</div>Andrew Abramowitz, Senior Counsel
<div class="lb-trans">Andrew Abramowitz，高級顧問
</div>Berger Montague
<div class="lb-trans">Berger Montague
</div>(215) 875-3015
<div class="lb-trans">(215) 875-3015
</div>[email protected]
<div class="lb-trans">[email protected]
</div>SOURCE Berger Montague
<div class="lb-trans">來源：Berger Montague
</div><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMDAzJk5ld3NJdGVtSWQ9REM5MDAzMiZUcmFuc21pc3Npb25fSWQ9MjAyNTEwMDMxMTM3UFJfTkVXU19VU1BSX19fX19EQzkwMDMy" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=DC90032&amp;Transmission_Id=202510031137PR_NEWS_USPR_____DC90032&amp;DateId=20251003"/>

Berger Montague 正在調查 Hims & Hers Health Inc.（NYSE: HIMS）董事會是否存在潛在的信託責任違約行為